Skip to main content

Peer Review reports

From: Combining 1,4-dihydroxy quininib with Bevacizumab/FOLFOX alters angiogenic and inflammatory secretions in ex vivo colorectal tumors

Original Submission
18 May 2020 Submitted Original manuscript
9 Jun 2020 Author responded Author comments - Susan A Kennedy
Resubmission - Version 2
9 Jun 2020 Submitted Manuscript version 2
17 Jun 2020 Reviewed Reviewer Report
30 Jun 2020 Reviewed Reviewer Report
1 Jul 2020 Reviewed Reviewer Report
1 Jul 2020 Reviewed Reviewer Report
1 Jul 2020 Reviewed Reviewer Report - Surya Pandey
2 Jul 2020 Reviewed Reviewer Report
30 Jul 2020 Author responded Author comments - Susan A Kennedy
Resubmission - Version 3
30 Jul 2020 Submitted Manuscript version 3
5 Aug 2020 Reviewed Reviewer Report
10 Aug 2020 Reviewed Reviewer Report
13 Aug 2020 Reviewed Reviewer Report
22 Aug 2020 Reviewed Reviewer Report
23 Aug 2020 Reviewed Reviewer Report - Surya Pandey
26 Aug 2020 Author responded Author comments - Susan A Kennedy
Resubmission - Version 4
26 Aug 2020 Submitted Manuscript version 4
30 Aug 2020 Reviewed Reviewer Report
1 Sep 2020 Reviewed Reviewer Report
14 Sep 2020 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
16 Sep 2020 Editorially accepted
2 Oct 2020 Article published 10.1186/s12885-020-07430-y

You can find further information about peer review here.

Back to article page